We are live on ! Find out more
CELG.RT icon

Bristol-Myers Squibb Rights
CELG.RT

27 hedge funds and large institutions have $299K invested in Bristol-Myers Squibb Rights in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,384% more capital inflows, than outflows

Capital inflows: $68.6K | Capital outflows: $4.63K

0.01% more ownership

Funds ownership: 0.02% → 0.02% (+0.01%)

4% less funds holding

Funds holding: 28 → 27 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Transcend Capital Advisors
Transcend Capital Advisors
New Jersey
+$50.8K
2
RIM
Redpoint Investment Management
Australia
+$9.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$8.73K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2.05K
2
Valeo Financial Advisors
Valeo Financial Advisors
Indiana
-$1K
3
PIMG
Patriot Investment Management Group
Tennessee
-$840
4
First Manhattan
First Manhattan
New York
-$431
5
Charter Research & Investment Group
Charter Research & Investment Group
Connecticut
-$229

CELG.RT Hedge Fund Activity: Q3 2020 in Review

27 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q3 2020, worth a combined $299K — up 21% from $248K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CELG.RT and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 0 added.

The largest buyer was Transcend Capital Advisors, opening a new position worth an estimated $50.8K. The largest seller was UBS Group, cutting an estimated $2.05K.

  • 27 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q3 2020, down from 28 in Q2 2020.
  • Funds reported $299K of Bristol-Myers Squibb Rights stock for Q3 2020, up 21% quarter-over-quarter.
  • 3 funds opened new Bristol-Myers Squibb Rights positions in Q3 2020 and 4 closed out, a net change of -1 holder.
  • The largest Bristol-Myers Squibb Rights buyer in Q3 2020 was Transcend Capital Advisors, an estimated $50.8K added.
  • The largest Bristol-Myers Squibb Rights seller in Q3 2020 was UBS Group, an estimated $2.05K sold.

Based on aggregated 13F filings for Q3 2020.